Pay in 4 interest-free payments of $39.38 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
The combination of Sorafenib and HS-173 synergistically inhibits cell proliferation in pancreatic cancer cell lines
Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo
1-2H3/t14-
InChiKey: WSSJONWNBBTCMG-UHFFFAOYSA-N
167465-36-3 (Zosuquidar trihydrochloride)
PT2399 verolimus The combination of Sorafenib andPT2399 is a potent and orally available antagonist of HIF 2 that selectively disrupts the heterodimerization of HIF 2 with HIF 1. Product information CAS Number: 1672662 14 4 Molecular Weight: 419. 32 Formula: C17H10F5NO4S Chemical Name: 3 [(1S) 7 (Difluoromethylsulfonyl) 2,2 difluoro 1 hydroxy indan 4 yl]oxy 5 fluoro benzonitrile Smiles: N#CC1=CC(F)=CC(=C1)OC1=CC=C(C2[C@H](O)C(F)(F)CC=21)S(=O)(=O)C(F)F InChiKey: MXUSGDMIHGLCNC HNNXBMFYSA N InChi:
US$ 99.00
US$ 16.89
US$ 24.59
US$ 70.00
US$ 17.39
US$ 18.39